Search Ontology:
ChEBI
pazopanib
- Term ID
- CHEBI:71219
- Synonyms
-
- 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
- GW 78603
- GW786034
- pazopanib
- pazopanibum
- Definition
- A pyrimidine that is 5-(pyrimidin-2-yl}amino-2-methylbenzenesulfonamide substituted at position 4 by a (2,3-dimethylindazol-6-yl)(methyl)amino group. Used as its hydrochloride salt for treatment of kidney cancer.
- References
-
- CAS:444731-52-6
- Drug_Central:4118
- LINCS:LSM-1114
- PMID:21394443
- PMID:21766486
- PMID:21811833
- PMID:22112314
- PMID:22190407
- PMID:22233389
- PMID:22341567
- PMID:22359392
- PMID:22595799
- PMID:22679111
- PMID:22688250
- PMID:22716487
- PMID:22733110
- PMID:22733795
- PMID:22759480
- PMID:22766517
- PMID:22830347
- PMID:22861374
- PMID:22917595
- PMID:22984765
- PMID:23054212
- PMID:23064954
- PMID:23072642
- PMID:23088634
- PMID:23135778
- Patent:US2008293691
- Patent:WO2006020564
- Patent:WO2007064753
- Patent:WO2007143483
- Patent:WO2011058179
- Patent:WO2011069053
- Patent:WO2011150044
- Patent:WO2012106302
- Reaxys:11646488
- Wikipedia:Pazopanib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from pazopanib
Phenotype where environments contain pazopanib
Phenotype modified by environments containing pazopanib
Human Disease Model